Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies.

M. G. Scott, G. C. Cuca, J. R. Petersen, L. R. Lyle, B. D. Burleigh, W. H. Daughaday

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

We identified two monoclonal antibodies that bind spatially distinct epitopes on insulin-like growth factor I (IGF-I). Using these two antibodies, we developed a simultaneous, two-site immunoradiometric assay (IRMA) specific for IGF-I. This IRMA has no detectable cross reactivity with insulin, proinsulin, prolactin, or somatotropin, and less than 2% crossreactivity with IGF-II. The assay response varies linearly with IGF-I concentrations of 0-800 micrograms/L in serum; the detection limit is about 10 micrograms/L. A comparison of 26 IGF-I serum values from the IRMA and from a previously reported IGF-I specific RIA gave a correlation coefficient of 0.96 with no substantial bias (slope = 1.10). IGF-I values for serum, as an aid in assessing growth abnormalities, are easily (only three pipetting steps) obtained in less than 4 h.

Original languageEnglish
Pages (from-to)2019-2023
Number of pages5
JournalClinical chemistry
Volume33
Issue number11
DOIs
StatePublished - Nov 1987
Externally publishedYes

Fingerprint Dive into the research topics of 'Specific immunoradiometric assay of insulin-like growth factor I with use of monoclonal antibodies.'. Together they form a unique fingerprint.

  • Cite this